Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
First Subject Enrolled in Phase 1 Study of MRX-5 2023-11-20 18:34
Sanyou's "STAL Platform" is a significant advancement in the field of drug discovery. 2023-11-18 08:00
CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update 2023-11-17 22:21
Taiwan Lubricate for academic research and health products development 2023-11-17 20:00
epitoMAP Inc., Animal Allergy Clinical Laboratories Inc. and Nippon Zenyaku Kogyo Co., Ltd. Enter into License Agreement 2023-11-17 16:00
WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange 2023-11-17 14:00
Antengene Presents Encouraging Clinical Data from Four Pipeline Programs at the 2023 R&D Day 2023-11-17 08:00
Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective in ACcomplisH China Phase 2 Trial 2023-11-16 22:00
TB Alliance Launches Five-Country Phase 2 Clinical Trial Evaluating Next-Generation TB Drug 2023-11-16 20:20
ACROBiosystems launches GMP-grade DLL4 Protein to accelerate stem cell manufacturing 2023-11-16 20:08
Henlius Reported Financial Results for the First Three Quarters of 2023: Total Revenue Exceeded RMB3.9 billion, Profitability Further Improved 2023-11-15 20:16
RemeGen to Present Telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients in a Late-Breaking Abstract Oral Presentation Session at the American College of Rheumatology 2023-11-15 16:35
"Read Medicine Labels" - How to Safely Use Green Chiretta Against COVID-19 2023-11-15 14:58
Riding the tide, realize the future: The BD paths for Chinese Biotech 2023-11-15 10:42
Noble Capital Markets Initiates Coverage on YS Biopharma With Outperform Rating and US$5.25 Price Target 2023-11-14 21:30
CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference 2023-11-14 20:47
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO 2023-11-14 08:27
Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023 2023-11-14 06:40
Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023 2023-11-14 06:40
Telix Announces Proposed Acquisition of QSAM Biosciences and Its Lead Therapy Candidate, CycloSam® 2023-11-14 06:33
1 28 29 30 31 32 375